SEARCH RESULTS FOR: ("Shape moulding machines for EPP Login [www.yyeps.com]EPS Machines")(9598 results)
WoundClot is a soluble dressing, based on cellulosic structure. In contact with liquids it forms absorbent gel which adheres to the wound surface to control bleeding.
WoundClot is intended to be used as a topical dressing for minor skin surface bleeding wounds such as minor cuts and minor abrasions.
CORE SCIENTIFIC CREATIONS LTD
3"X23.6" OTC FDA
In Commercial Distribution
- 17290016339410 ()
- 07290016339413 ()
101586901
- Plant polysaccharide haemostatic agent, bioabsorbable
WoundClot is a soluble dressing, based on cellulosic structure. In contact with liquids it forms absorbent gel which adheres to the wound surface to control bleeding.
WoundClot is intended to be used as a topical dressing for minor skin surface bleeding wounds such as minor cuts and minor abrasions.
CORE SCIENTIFIC CREATIONS LTD
3"X8" OTC FDA
In Commercial Distribution
- 17290016339403 ()
- 07290016339406 ()
101582901
- Plant polysaccharide haemostatic agent, bioabsorbable
WoundClot is a soluble dressing, based on cellulosic structure. In contact with liquids it forms absorbent gel which adheres to the wound surface to control bleeding.
WoundClot is intended to be used as a topical dressing for minor skin surface bleeding wounds such as minor cuts and minor abrasions.
CORE SCIENTIFIC CREATIONS LTD
2"X2" OTC FDA
In Commercial Distribution
- 17290016339397 ()
- 07290016339390 ()
101555901
- Plant polysaccharide haemostatic agent, bioabsorbable
WoundClot is a soluble dressing, based on cellulosic structure. In contact with liquids it forms absorbent gel which adheres to the wound surface to control bleeding.
WoundClot is intended to be used as a topical dressing for minor skin surface bleeding wounds such as minor cuts and minor abrasions.
CORE SCIENTIFIC CREATIONS LTD
8"X12" OTC FDA
In Commercial Distribution
- 17290016339380 ()
- 07290016339383 ()
101523901
- Plant polysaccharide haemostatic agent, bioabsorbable
WoundClot is a soluble dressing, based on cellulosic structure. In contact with liquids it forms absorbent gel which adheres to the wound surface to control bleeding.
WoundClot is intended to be used as a topical dressing for minor skin surface bleeding wounds such as minor cuts and minor abrasions.
CORE SCIENTIFIC CREATIONS LTD
4"X4" OTC FDA
In Commercial Distribution
- 07290016339376 ()
- 17290016339373 ()
101511901
- Plant polysaccharide haemostatic agent, bioabsorbable
WoundClot is a soluble dressing, based on cellulosic structure. In contact with liquids it forms absorbent gel which adheres to the wound surface to control bleeding.
WoundClot is intended to be used as a topical dressing for minor skin surface bleeding wounds such as minor cuts and minor abrasions.
CORE SCIENTIFIC CREATIONS LTD
3" X 39" OTC FDA
Not in Commercial Distribution
- 17290016339304 ()
- 07290016339307 ()
101581901
- Plant polysaccharide haemostatic agent, bioabsorbable
The KGTI phalangeal component is fixed by means of a stem, which is inserted into the medullary canal of the phalanx. The implant is indicated for use in patients with osteoarthritis of the first metatarsophalangeal joint, trauma involving the first metatarsophalangeal joint, hallux rigidus with degenerative joint disease or arthritis.
Ascension Orthopedics, Inc.
012016
Not in Commercial Distribution
- M2480120161 ()
- 10381780065487 ()
- .816 in dia x .662 in L; Size 3
012016
- Partial metatarsophalangeal joint prosthesis
The KGTI phalangeal component is fixed by means of a stem, which is inserted into the medullary canal of the phalanx. The implant is indicated for use in patients with osteoarthritis of the first metatarsophalangeal joint, trauma involving the first metatarsophalangeal joint, hallux rigidus with degenerative joint disease or arthritis.
Ascension Orthopedics, Inc.
012014
Not in Commercial Distribution
- M2480120141 ()
- 10381780065470 ()
- .776 in dia x .662 in L; Size 2
012014
- Partial metatarsophalangeal joint prosthesis
The KGTI phalangeal component is fixed by means of a stem, which is inserted into the medullary canal of the phalanx. The implant is indicated for use in patients with osteoarthritis of the first metatarsophalangeal joint, trauma involving the first metatarsophalangeal joint, hallux rigidus with degenerative joint disease or arthritis.
Ascension Orthopedics, Inc.
012012
Not in Commercial Distribution
- M2480120121 ()
- 10381780065463 ()
- .734 in dia x .662 in L; Size 1
012012
- Partial metatarsophalangeal joint prosthesis
The KGTI phalangeal component is fixed by means of a stem, which is inserted into the medullary canal of the phalanx. The implant is indicated for use in patients with osteoarthritis of the first metatarsophalangeal joint, trauma involving the first metatarsophalangeal joint, hallux rigidus with degenerative joint disease or arthritis.
Ascension Orthopedics, Inc.
012010
Not in Commercial Distribution
- M2480120101 ()
- 10381780065456 ()
- .672 in dia x .662 in L; Size 0
012010
- Partial metatarsophalangeal joint prosthesis